Stockreport

BridgeBio Pharma Inc (BBIO) Reports Q4 and Full Year 2023 Financials, Advances Key Clinical Trials [Yahoo! Finance]

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF Operating Costs and Expenses : Increased to $616.7 million for the full year 2023, up from $589.9 million in the previous year. Net Loss : Grew to $(653.3) million fo [Read more]